A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform
Anna Malczyk(German Center for Infection Research), Michael D. Mühlebach(Paul Ehrlich Institut)
Cited by 124
Related Papers
Enhanced lysis by bispecific oncolytic measles viruses simultaneously using HER2 /neu or EpCAM as target receptors
|Molecular Therapy — Oncolytics|2016|22